This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Ruth Rosemary French: Innovator in Immunomodulatory Antibodies
Introduction
Ruth Rosemary French is a prominent inventor based in Southampton, GB. She has made significant contributions to the field of immunology, particularly through her work on antibodies that have therapeutic applications. With a total of 2 patents, her innovations are paving the way for advancements in cancer treatment.
Latest Patents
Ruth's latest patents focus on immunomodulatory antibodies. These inventions relate to antibodies specific for 4-1BB and OX40, along with methods for utilizing these antibodies and their therapeutic uses. Her work in this area is crucial for developing new treatments that can enhance the immune response against cancer.
Career Highlights
Ruth is currently associated with Cancer Research Technology Limited, where she continues to push the boundaries of cancer research. Her dedication to innovation in this field has established her as a key figure in the development of new therapeutic strategies.
Collaborations
Ruth has collaborated with notable professionals in her field, including Aymen Al-Shamkhani and Hak Tak Claude Chan. These partnerships have further enriched her research and contributed to the advancement of immunotherapy.
Conclusion
Ruth Rosemary French is a trailblazer in the development of immunomodulatory antibodies, with her work holding promise for future cancer therapies. Her contributions are vital to the ongoing fight against cancer, and her patents reflect her innovative spirit and commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile